Occlusive Arterial Disease (OAD)-Pipeline Review, H2 2012 New Report
Occlusive Arterial Disease (OAD) - Pipeline Review, H2 2012, provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Occlusive Arterial Disease (OAD), complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Occlusive Arterial Disease (OAD). Occlusive Arterial Disease (OAD) - Pipeline Review, Half Year is built using data and information sourced from databases, Company/University websites, SEC filings, investor...
View full press release